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Synopsis
In the ER (endoplasmic reticulum) of human cells, disulfide bonds are predominantly generated by the two isoforms
of Ero1 (ER oxidoreductin-1): Ero1α and Ero1β. The activity of Ero1α is tightly regulated through the formation of
intramolecular disulfide bonds to help ensure balanced ER redox conditions. Ero1β is less tightly regulated, but
the molecular details underlying control of activity are not as well characterized as for Ero1α. Ero1β contains an
additional cysteine residue (Cys262), which has been suggested to engage in an isoform-specific regulatory disulfide
bond with Cys100. However, we show that the two regulatory disulfide bonds in Ero1α are likely conserved in Ero1β
(Cys90–Cys130 and Cys95–Cys100). Molecular modelling of the Ero1β structure predicted that the side chain of Cys262
is completely buried. Indeed, we found this cysteine to be reduced and partially protected from alkylation in the ER of
living cells. Furthermore, mutation of Cys100 – but not of Cys262 – rendered Ero1β hyperactive in cells, as did mutation
of Cys130. Ero1β hyperactivity induced the UPR (unfolded protein response) and resulted in oxidative perturbation of
the ER redox state. We propose that features other than a distinct pattern of regulatory disulfide bonds determine
the loose redox regulation of Ero1β relative to Ero1α.
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response (UPR)
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INTRODUCTION
In the ER (endoplasmic reticulum), optimal redox conditions
are maintained to facilitate formation of native disulfide bonds
in secretory proteins. In mammalian cells, disulfide bonds are
mainly generated by Ero1 (ER oxidoreductin-1) [1,2]. Proteins
of the Ero1 family comprise two conserved di-cysteine active
sites [3] (Figure 1). The so-called inner active site sits adjacent
to a FAD moiety inside a four-helix bundle, whereas the outer
active site (containing the two ‘shuttle’ cysteines) is located on
a flexible loop region [4,5]. The inner active site is oxidized
by molecular oxygen via FAD, which leads to generation of
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hydrogen peroxide [6–8]. In turn, the inner active site oxidizes
the shuttle cysteines by thiol–disulfide exchange [9]. The shuttle
cysteines then oxidize active-site cysteines in members of the PDI
(protein disulfide-isomerase) family [2, 8, 10–12]. As the final
step in the Ero1–PDI disulfide relay, PDIs introduce disulfide
bonds into newly synthesized proteins in the ER [13].
Two isoforms of Ero1 have been identified in nearly all ver-
tebrates studied so far [14] including humans: Ero1α and Ero1β
[15,16]. Whereas Ero1α is widely expressed, Ero1β is pre-
dominantly found in select tissues, such as the pancreas and
salivary gland [16,17]. Both Ero1 isoforms are up-regulated by
the UPR (unfolded protein response), which is a transcriptional
and translational programme that is induced by accumulation of
c© 2014 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/)
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Figure 1 Disulfide bonds in Ero1β and Ero1α
(A) Schematic representation of the proposed disulfide pattern in the OX redox form of Ero1β as reported by Wang et al.
[7]. (B) Proposed disulfide bond pattern in Ero1β based on the present study. (C) Disulfide bond pattern in Ero1α OX2
verified by mass spectrometry [23,24] and crystallography [4]. The cysteine residues are shown in black, magenta (outer
active site), green (inner active site) and red (Cys262 in Ero1β) with amino acid numbering. Disulfide bonds are depicted
as thick grey (likely structural), black (active site) or red (reported regulatory function; Ero1β [7,32] and this study, Ero1α
[4,23,24,47]) lines. The thick orange line at Cys166 indicates the connection to a potential (but unidentified) disulfide
partner. The flexible regions are coloured in light blue and fork-like branches depict predicted high-mannose N-linked
glycans. The β -hairpin region shown to interact with PDI is coloured orange.
misfolded proteins in the ER (designated ER stress). The UPR
seeks to restore ER homoeostasis, for example by decreasing
the ER protein load through translational arrest and in paral-
lel up-regulating chaperones to assist folding [18]. PERK [PKR
(double-stranded-RNA-dependent protein kinase)-like endoplas-
mic reticulum kinase], Inositol-requiring enzyme 1α (Ire1α)
and ATF6α (activating transcription factor 6α) are the three
transmembrane transducers that initiate ER-to-nucleus signalling
upon ER stress. Whereas the PERK pathway is involved in up-
regulating Ero1α [19], Ero1β is induced by the XBP1s transcrip-
tion factor (which is activated by Ire1α) [20] and ATF6α [21].
Apart from the first three cysteines in Ero1α (Cys35, Cys37
and Cys46), the 12 additional cysteines are conserved in the ver-
tebrate branch of the Ero1 family [22,23]. In addition to these
12 cysteines, human Ero1β contains a cysteine residue in posi-
tion 262 (Cys262) (Figure 1). The disulfide pattern in Ero1α has
been mapped by mass spectrometry [23,24] and crystallography
[4] (Figure 1). In contrast to Ero1 from Saccharomyces cerevisiae
(Ero1p) [5], the Ero1α shuttle cysteines (Cys94 and Cys99) can en-
gage in regulatory disulfide bonds with non-active-site cysteines
(Cys131 and Cys104, respectively) [23,25]. The presence of these
two disulfide bonds blocks the outer active site and thus inhibits
the activity of Ero1α [23,25]. In the cell, formation and reduction
of these inhibitory disulfide bonds depend on the redox state of
PDI [23]. This gives rise to a tightly regulated homoeostatic feed-
back mechanism where Ero1α is only active when oxidized PDI
is scarce [23]. Since the ER glutathione redox buffer influences
the redox state of PDI [26,27], Ero1α activity is modulated by the
ratio between oxidized and reduced glutathione mediated through
PDI [28]. Similarly, redox regulation of Ero1p in S. cerevisiae is
also influenced by the redox state of PDI and glutathione [29–31].
Moreover, the ratio between oxidized and reduced glutathione is
tightly balanced in the ER in human cells, which is at least in part
a consequence of the Ero1 feedback regulation [2].
In comparison with Ero1α, Ero1β activity does not seem to be
as tightly regulated. Whereas overexpressed Ero1α-WT (wild-
type Ero1α) is predominantly inactive and therefore has a subtle
effect on the redox state of the PDI homologue ERp57 [23,24],
overexpression of Ero1β-WT hyperoxidizes ERp57, i.e. leads to
a larger fraction of the molecules with active-site cysteines in
the disulfide-bonded state [23,32]. Similarly, Ero1β-WT is more
active than Ero1α-WT in an in vitro oxidation assay performed
with PDI as the substrate [7]. On non-reducing SDS–PAGE gels
exogenous Ero1β expressed in mammalian cells migrates as two
distinct redox species, with the distribution between the faster mi-
grating (OX) and slower migrating species (Red) varying between
experiments [23,33,34]. Similar to Ero1α [25], an initial shift
from the OX to the Red species of Ero1β was observed during the
catalysis of thioredoxin oxidation in vitro [7]. When thioredoxin
was completely oxidized, the redox state of Ero1β reverted to
the OX species [7]. Thus, Ero1β activity is also regulated by
intramolecular disulfides.
In Ero1α, a cysteine-to-alanine mutant of Cys104 and Cys131
(Ero1α-C104A/C131A) displays hyperactivity since it can no
longer form the two regulatory disulfides, but retains the two
residues of the outer active site, Cys94 and Cys99 [24,25].
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Regulatory disulfide bonds in Ero1β
Recently, we showed that overexpression in human cells of the
equivalent Ero1β mutant (Ero1β-C100A/C130A) gave rise to
more pronounced hyperoxidation of ERp57 relative to overex-
pression of Ero1β-WT [32], suggesting that the regulatory mech-
anism is shared for Ero1α and Ero1β. However, Ero1β contains
an additional cysteine residue (Cys262), which is not present in
Ero1α. A disulfide bond between Cys100 and Cys262 was recently
proposed to be present in Ero1β purified from Escherichia coli
[7]. Moreover, Ero1β-C100A displayed slowed oxidation kinet-
ics relative to Ero1β-WT [7], suggesting that the presence of the
proposed Cys100–Cys262 disulfide bond increases Ero1β activity.
On this background, we decided to further investigate the inter-
play between intramolecular disulfide bonds and regulation of
activity in Ero1β.
MATERIALS AND METHODS
Primers and plasmids
Human Ero1β-myc6his ([16]; a gift from R. Sitia, Milan) cloned
into the pcDNA5/FRT/TO vector [23] was used as a template
for QuikChange mutagenesis (Stratagene) to introduce Cys-to-
Ala mutations. The following primer was used to generate the
C262A mutation (only the sense strand is shown): C262A 5′-GA-
CTTCATGCTAGCATCAATTTACATCTAGCCGCAAATTAT-
CTTTTGG-3′. The C100A and C130A mutations have been
described before [32]. All plasmids were sequenced to confirm
the correct DNA sequence of the inserts.
Cell culture
Dox (doxycycline)-inducible Flp-In T-REx HEK-293 (Life Tech-
nologies) cell lines were generated and grown as previously de-
scribed [23]. Ero1β expression was induced for 24 h (unless
otherwise stated) using 1 μg/ml Dox (Sigma). For ER stress in-
duction, cells were treated with either 5 μM thapsigargin (Sigma)
or 2.5 μg/ml tunicamycin (Sigma) for the indicated time.
Sample preparation and AMS
(4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic
acid) modification
Cells were treated with NEM (N-ethylmaleimide) and sub-
sequently lysed as described elsewhere [35]. The AMS (Life
Technologies) modification protocol has been described previ-
ously [35]. Reduced and oxidized control lysates were obtained
from cells treated with 10 mM DTT (dithiothreitol) or 5 mM
diamide (both Sigma) for 5 min at 37 ◦C in full growth medium.
Antibodies and Western blotting
The following mouse monoclonal antibodies were used: αHis
(Tetra-His, Qiagen), αmyc (9E10, Covance), αβ-actin (AC-15,
Sigma). The rabbit polyclonal antisera used were: αBiP (G8918,
Sigma), αERp57 (a gift from A. Helenius, Zu¨rich, Switzerland),
αHERP (a gift from L. Hendershot, Memphis, TN, U.S.A.). West-
ern blotting was performed as previously described [24]. The
shown Western blots are representative of at least two independ-
ent experiments.
Redox state analysis of Ero1β by TCA
(trichloroacetic acid) precipitation and alkylation of
free thiols
Cells cultivated to 60–80 % confluency in 6 cm dishes were
washed twice in PBS. They were then concomitantly lysed
and precipitated by incubation in 10 % (v/v) TCA for 15 min
on ice. Cells were transferred to an Eppendorf tube, centri-
fuged (16 100 g, 4 ◦C, 15 min) and the supernatant was dis-
carded. Pellets were washed once in ice-cold acetone, centrifuged
(16 100 g, 4 ◦C, 15 min) and resuspended in 100 μl 100 mM Tris–
HCl pH 7.0, 8 % (v/v) glycerol, 2 % (w/v) SDS, 10 % dimethyl
sulfoxide, 0.01 % (w/v) bromocresol purple and 20 mM NEM.
Samples were neutralized by drop-wise addition of 1 M Tris–
HCl, pH 7.5, 2 % SDS until samples turned purple (bromocresol
purple changes colour between pH 5.2 and 6.8). The pellets were
subsequently dissolved by sonication, incubated at RT in the
dark for 1 h and the redox state of Ero1β was determined by
non-reducing Western blotting.
RESULTS
Structure homology modelling of Ero1β predicts
Cys262 to be buried in the structure
The amino acid sequences of Ero1β are highly conserved
between orthologues (Supplementary Figure S1 available
at http://www.bioscirep.org/bsr/034/bsr034e103add.htm). Thus,
potential roles of cysteine residues in regulatory disulfide bonds
based on evolutionary conservation could not be inferred from
a multiple sequence alignment. Instead, we used structure ho-
mology modelling of Ero1β to assess the proposed disulfide
patterns in the protein (Figures 1A and 1B). The protein structure
prediction software SWISS-MODEL [36] was used to predict
the three-dimensional structure of Ero1β based on the crystal
structure of inactive Ero1α, a mutant in essence corresponding to
the OX2 form ([4]; PDB ID: 3AHR) (Figure 2A). The sequences
of mature Ero1α and Ero1β are highly similar [14] with a se-
quence identity of 65 %. As expected from the high sequence
conservation, the α-helical fold in Ero1α was predicted to be
preserved in Ero1β including the four-helix bundle involved in
FAD binding (Figure 2A, red-coloured α-helices). The structure
of the flexible region (residues 86–130) comprising the proposed
Cys90–Cys130 or the Cys95-Cys100 disulfide bonds could not be
reliably modelled (Figure 2A).
In contrast to the cysteines in the flexible region, Cys262 is loc-
ated at the end of a conserved helix [14], which is part of the four-
helix bundle (Figure 2A). Moreover, Cys262 is positioned close
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Figure 2 Structural model of Ero1β
(A) Superimposition of the structure of inactive Ero1α (PDB ID: 3ahr;
[4]) and a structural model of Ero1β. The latter was homology mod-
elled based on the structure of inactive Ero1α using the SWISS-MODEL
software [36]. Predicted flexible regions (see Figure 1) are not depic-
ted. The approximate position of the flexible region comprising residues
86–130 in Ero1β is indicated. In Ero1β, the α-helices of the four-helix
bundle are shown in red, the remainder of the molecule in orange
and the cysteine residue side chains are depicted as spheres (yel-
low: sulfur, cyan: carbon) with amino acid numbering indicated. Ero1α
is depicted in blue and the FAD moiety (stick model) in yellow. (B)
Zoom of the structural overlay in (A). The predicted hydrogen bond (en-
circled) between the Ero1β Cys262 SH-group and the carbonyl O (red) of
Asn258 is shown by the broken yellow line. In the model, the distance
between the S and O atoms is 2.74 A˚. This figure was created in PyMOL
(http://www.pymol.org).
to a protruding β-hairpin, which is critical for the interaction
with PDI [37]. The equivalent residue in Ero1α (Ser263) is com-
pletely buried. Similarly, in the Ero1β model, Cys262 is predicted
to have a relative accessible surface area of 0 (as calculated by the
ASAView software [38] and the GETAREA method [39]), which
strongly suggests that Cys262 in Ero1β is buried in the native
structure. Moreover, the side chain − SH (Cys262)/ − OH (Ser263)
is predicted to form a hydrogen bond with the backbone carbonyl
group of Asn258/Asn259, respectively (Figure 2B). This hydrogen
bond seems to be part of a conserved hydrogen bond network,
including hydrogen bonds from the side chain of Asn258/Asn259
to FAD, which helps stabilize the structure in the vicinity of the
bound cofactor. Finally, we also note that in Xenopus tropicalis
Ero1β, a serine residue is found in place of Cys262 (Supplement-
ary Figure S1), indicating that a cysteine is not strictly necessary
at this position as may have been expected if it played an import-
ant function in regulating the activity of the enzyme.
SDS–PAGE mobility of Ero1β mutants suggests
conservation of regulatory disulfide bonds in Ero1α
and Ero1β
To investigate the structural importance of intramolecular di-
sulfide bonds in human Ero1β, we expressed Ero1β cysteine
mutants in human cells and analysed the mobility of these mutants
by non-reducing SDS–PAGE. Apart from already established
stable cell lines for ectopic inducible expression of Ero1β-WT
[23] and Ero1β–C100A/C130A [32], we generated three new
inducible cell lines for the following mutants: Ero1β-C100A,
Ero1β–C130A and Ero1β–C262A. As compared with Ero1β-
WT, Ero1β–C100A and Ero1β–C262A showed similar expres-
sion levels, whereas the expression levels of Ero1β–C130A and
Ero1β–C100/130A were lower (Figure 3A). Importantly, none
of the cell lines overexpressing Ero1β mutants of Cys100 and/or
Cys130, which turned out to be hyperactive (see below), expressed
more protein than the Ero1β-WT-expressing cell line.
As previously observed [33], the monomeric form of exogen-
ous Ero1β-WT migrated as two distinct redox species (Red and
OX) when cells were treated with NEM to alkylate free thiols in
situ prior to lysis (Figure 3B, lane 2 and Figure 3C, lane 3). How-
ever, upon TCA precipitation with subsequent NEM treatment,
monomeric Ero1β-WT migrated as one redox species (Figure 3D,
lane 4). TCA precipitation rapidly quenches thiol–disulfide ex-
change reactions and denatures proteins, enabling alkylation of
thiols buried in the native structure [40]. When cells are in situ
NEM-treated, approximately 20 % of the cellular protein thiols
have been shown to be inaccessible to NEM [41]. Such NEM
inaccessibility is thought to be a consequence of these thiols be-
ing buried in the native structure [40]. We therefore suggest that
inefficient alkylation of (a) free thiol(s) buried in the structure
of Ero1β gives rise to rearrangement of disulfide bonds upon
denaturation, leading to the appearance of the Red Ero1β redox
form (Figures 3B and 3C). Conversely, when all free thiols are
efficiently alkylated, Ero1β-WT is preserved as a single redox
species visible on SDS–PAGE gels (Figure 3D).
The SDS–PAGE mobility of the Ero1β variants on non-
reducing gels (Figure 3D) is consistent with Ero1β having a
similar pattern of disulfide bonds as Ero1α (Figures 1B and
1C). We were able to detect a relatively small migration shift
between Ero1β-WT and Ero1β-C100A (Figure 3D, lanes 4–5)
suggesting that Cys100 is not engaged in a long-range disulfide
bond. In contrast, a larger shift was observed upon mutation of
Cys130 (Figure 3D, lanes 6–7) consistent with removal of the
longer-ranging Cys90–Cys130 disulfide bond. No redox species
of Ero1β-C100A co-migrated with Ero1β–C130A (Figure 3D,
lanes 5–6), suggesting that the Cys90–Cys130 disulfide bond is
intact in Ero1β–C100A.
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Regulatory disulfide bonds in Ero1β
Figure 3 SDS–PAGE mobility of Ero1β variants suggests that Ero1α and Ero1β share their sets of regulatory disulfide
bonds
(A) Expression of His- and Myc-tagged Ero1β variants was induced with Dox for 24 h and cells were NEM treated to
alkylate-free thiols. Equal amounts of protein from lysates were analysed by reducing SDS–PAGE and Western blotting
using αHis (Ero1β) and αActin (loading control) to compare expression levels of Ero1β variants. (B,C) Cell lysates were
obtained as in (A). The SDS–PAGE mobility of the Ero1β variants was analysed under non-reducing (Non-red) or reducing
(Red) conditions by αmyc or αHis Western blotting. The open and filled circles indicate the previously described OX and Red
redox forms of Ero1β WT [33], respectively, and vertical hairlines denote removal of lanes. Asterisk denotes a background
band. (D) Expression of Ero1β variants was induced as in (A). Cells were subjected to TCA precipitation to rapidly quench
thiol–disulfide exchange reactions and to denature cellular proteins. Precipitates were redissolved in a buffer containing
NEM to alkylate free thiols. Subsequently, the SDS–PAGE mobility of the Ero1β variants was analysed under non-reducing
conditions by αHis Western blotting. Section signs (§) indicate possible Ero1β mixed-disulfide dimeric species and the
asterisk (*) denotes a background band.
Figure 4 Hyperoxidation of ERp57 is intensified by removal of regulatory disulfide bonds in Ero1β
(A–C) Where indicated, expression of Ero1β variants was induced with Dox for 24 h. Prior to lysis, cells were treated with
NEM to alkylate free thiols. After cell lysis, cysteines present in disulfides were reduced and decorated with AMS. Such
AMS modification of active-site cysteines originally present in the oxidized state gives rise to slower SDS–PAGE mobility
compared with the (NEM-decorated) pool of ERp57 containing reduced active-site cysteines. The cellular redox state of
ERp57 was visualized by Western blotting. DTT and Diamide (Dia) treated-cells were used to show the mobility of fully
oxidized (Ox) and reduced (Red) ERp57. A vertical hairline denotes removal of lanes.
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A fraction of Ero1β is present as a disulfide-bonded homo-
dimer in human cells [33] and when expressed in bacteria [7].
Moreover, Ero1β engages in heterodimeric mixed-disulfide spe-
cies with PDI and ERp44 in human cells [42]. The possible di-
meric species involving Ero1β-WT and Ero1β–C262A were sim-
ilar (Figure 3D, lanes 3–4), suggesting that Cys262 is not involved
in formation of mixed-disulfide dimeric species. Notably, Ero1β–
C262A did not migrate slower than Ero1β-WT (Figure 3D, lanes
3–4), suggesting that Cys262 is not engaged in a long-range disulf-
ide bond. Instead, Ero1β–C262A was present exclusively as the
OX redox species in lysates from cells treated in situ with NEM
(Figure 3C, lane 2), and as a single redox species co-migrating
with Ero1β-WT in lysates from cells subjected to TCA precip-
itation (Figure 3D, lane 3). This clearly suggests that non-native
ex vivo disulfide shuffling in lysates of in situ NEM-treated cells
observed for Ero1β-WT (Figures 3B and 3C) depends on the
presence of Cys262, and that this residue is inaccessible to NEM
in the native structure.
Based on these results, we propose that the regulatory disulfide
bonds in Ero1α (Cys94–Cys131 and Cys99–Cys104) are conserved
in Ero1β (Cys90–Cys130 and Cys95–Cys100) and that Cys262 con-
stitutes a poorly accessible free thiol in the native structure. The
deduced disulfide pattern in the OX redox form of Ero1β is shown
in Figure 1(B).
Removal of either of the regulatory disulfide bonds
increases the activity of Ero1β in cells
We next wanted to assess the relative contribution of the proposed
disulfide bonds (Cys90–Cys130 and Cys95–Cys100) to the regula-
tion of Ero1β activity. First, we analysed the cellular redox state
of ERp57, as assessed by differential alkylation of the active-
site cysteines. This assay probes the ratio of ERp57 molecules
with active-site cysteines in the oxidized and reduced state, re-
spectively, and has been used routinely in the field as readout for
changes in the ER redox environment [23,27,43]. Mutation of
Cys100 and Cys130 alone or in combination increased the hyper-
oxidizing effect of Ero1β on the redox state of ERp57 relative to
Ero1β-WT (Figures 4A and 4B). This suggests that both disulfide
bonds (Cys90–Cys130 and Cys95–Cys100) are involved in inhibit-
ing the activity of Ero1β. Consistent with Cys262 not being in-
volved in regulation of Ero1β activity, overexpression of Ero1β–
C262A showed only a minor hyperoxidizing effect on ERp57
(Figure 4C). It should be noted that consistent with our previous
studies, and as noted before [2], the ERp57 redox state differed
between individual experiments likely reflecting physiological
variations. This, however, does not affect the overall conclusions
concerning the relative oxidizing effects of overexpressing dif-
ferent Ero1β variants.
We recently showed that a deregulated Ero1α mutant (Ero1α-
C104A/C131A) markedly activated the UPR as a result of its
increased oxidase activity when overexpressed in HEK-293 cells
(human embryonic kidney cells) [24]. To study whether overex-
pression of Ero1β also induces the UPR, we analysed the protein
levels of the two established UPR targets, BiP (immunoglobulin
heavy-chain-binding protein) and HERP (homocysteine-induced
ER protein) [44]. As expected from the loose regulation of Ero1β
(Figure 4), BiP and HERP levels were moderately increased upon
expression of Ero1β-WT (Figures 5A–5D). These effects were
more pronounced upon mutation of Cys100 and Cys130 alone or
in combination (Figures 5A–5C), correlating with the impact of
these mutants on the redox state of ERp57 (Figures 4A and 4B).
Overexpression of Ero1β-C262A showed a similar degree of
UPR induction as Ero1β-WT (Figure 5D). These findings sug-
gested that Cys262 is not involved in regulating Ero1β activity,
and is in keeping with our proposed disulfide pattern of Ero1β
(Figure 1B).
DISCUSSION
Tight regulation of Ero1α activity is important to maintain bal-
anced ER redox conditions [23–25]. We propose that the regu-
latory disulfide bonds in Ero1α and Ero1β are conserved (Fig-
ures 1B and 1C). This conclusion is based on several lines of
evidence, including molecular modelling of the Ero1β structure
(Figure 2), SDS–PAGE mobility analysis of Ero1β mutants (Fig-
ures 3B–3D) and ER redox (Figure 4) and ER stress readouts
(Figure 5). Overall, the findings that overexpression of Ero1β
mutants devoid of Cys100 and/or Cys130 induces the UPR, hyper-
oxidizes ERp57 and that Ero1β-C100A/C130A hyperoxidizes
an ER-localized glutathione sensor [32], indicate that the under-
lying mechanism is likely to involve an oxidizing perturbation
of the ER redox environment, which in turn results in protein
misfolding and therefore activation of the UPR.
In a previous study [7], Ero1β-C262A purified from E. coli
displayed a prominent slow-migrating redox species when com-
pared with Ero1β-WT by non-reducing SDS–PAGE, indicating
the loss of a long-range disulfide. Furthermore, analysis of tryptic
fragments supported the presence of a Cys100–Cys262 disulfide
bond. Finally, the Ero1β-C100A mutant was less active in vitro
than Ero1β-WT, suggesting that the presence of the proposed
Cys100–Cys262 disulfide bond positively regulates the activity of
Ero1β.
Here, we expressed Ero1β (and mutants thereof) in its native
environment in the ER of human cells and reached the conclusion
that a disulfide bond between Cys100 and Cys262 is not likely to
form. Thus, mutation of Cys100 rendered Ero1β hyperactive and
overexpression of Ero1β-C262A showed effects comparable to
Ero1β-WT overexpression. We also provide two-fold evidence
that Cys262 is a solvent inaccessible residue in the native structure
of Ero1β. First, a fraction of Ero1β-WT molecules rearrange into
a redox species that migrates as the Red form upon in situ NEM
treatment in a Cys262-dependent manner, suggesting that
NEM cannot gain access to Cys262 under native conditions.
Secondly, a homology model of Ero1β based on the crystal struc-
ture of Ero1α places Cys262 in a non-solvent exposed site in a
highly conserved α-helix. Collectively, these findings strongly
support the conclusion that Cys262 does not engage in an in-
tramolecular disulfide bond with Cys100. To verify the proposed
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Figure 5 Absence of regulatory disulfide bonds in Ero1β increases induction of the unfolded protein response (UPR)
(A–D) Expression of Ero1β variants was induced with doxycycline (Dox) for the indicated periods of time. Expression
levels of BiP and HERP were analysed by Western blotting using αActin as loading control. The mock cell line is stably
transfected with an empty vector. Cells were either treated with 5 μM thapsigargin (Tg) for 18 h (A) and 6 h (B) or treated
with 2.5 μg/ml tunicamycin (Tm) for 20 h (C, D) to generate positive control lysates for induction of the UPR.
disulfide pattern, we also sought to map the intramolecular disulf-
ides in Ero1β purified from human cells by mass spectrometry,
as has previously been achieved for Ero1α [23]. Unfortunately,
the results obtained by this approach were ambiguous (H. G.
Hansen, L. Ellgaard and F. Huba´lek, unpublished work), which
was likely a result of disulfide bond scrambling in the course of
sample preparation.
Using TCA precipitation and subsequent NEM treatment, we
demonstrated that the Red form of Ero1β [33] is likely an arte-
fact of inefficient thiol alkylation, indicating that overexpressed
Ero1β is present solely as the OX redox species. Unfortunately,
the redox state of endogenous Ero1β assessed by SDS–PAGE
mobility under non-reducing conditions is currently unknown.
Moreover, we currently do not know why Ero1β migrates 5–
7 kDa faster than Ero1α on non-reducing SDS–PAGE gels [23],
even though the predicted molecular mass of mature Ero1β is
only 1–2 kDa smaller than the corresponding mass of mature
Ero1α. Since deglycosylation of Ero1β gives rise to a more pro-
nounced mobility shift on SDS–PAGE gels as compared with
Ero1α [16], the presence of N-linked glycans cannot explain the
unexpectedly large difference in SDS–PAGE mobility between
Ero1α and Ero1β.
As Ero1α and Ero1β likely share their sets of regulatory di-
sulfide bonds, features other than a distinct pattern of disulfide
bonds must determine the loose redox regulation of Ero1β re-
lative to Ero1α. Mutation of the Cys394–Phe–Lys–Cys397 inner
active site sequence of Ero1α to the Ero1β sequence (Cys393–
Asp–Lys–Cys396) substantially increases the oxidase activity of
Ero1α [7]. This suggests that Asp394 in Ero1β contributes to the
apparently loose redox regulation of Ero1β relative to Ero1α.
As previously proposed [22], the loose regulation of Ero1β
activity relative to Ero1α could be explained by a higher reduc-
tion potential of the regulatory disulfide bonds in Ero1β. The
high expression of Ero1β in the pancreas and salivary gland
indicates a specific role of the protein in secretory tissues. Ac-
cordingly, oxidative folding of pro-insulin is impeded in pancre-
atic islet cells derived from Ero1β-compromised mice, an effect
that is not exacerbated by concomitantly compromising Ero1α
function [45]. However, increasing disulfide-bond formation by
exogenous Ero1α expression stimulates oxidative folding of pro-
insulin [46]. These observations suggest that the loose regulation
of Ero1β activity could have evolved to optimally support the
high demand of disulfide bonds in secretory tissues.
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Regulatory disulfide bonds in Ero1β
Figure S1 Evolutionary conservation of Ero1β
A multiple sequence alignment of Ero1β orthologs was performed with Muscle [1] using the following UniProt entries.
Xenopus tropicalis (frog; F6ULN4); Gallus gallus (chicken; E1C917); Anolis carolinensis (lizard; G1KAL4); Monodelphis
domestica (opossum; F7CL82); Mus musculus (mouse: Q8R2E9); Canis familiaris (dog; F1Q091); Homo sapiens (human;
Q86YB8); Danio rerio (zebrafish; E7F2A8); Oryzias latipes (rice fish; H2L719); Takifugu rubripes (pufferfish; H2TT03). Black
boxes indicate amino acid identities and grey boxes show amino acid similarities when found in at least seven of the nine
sequences. The human sequence is shown in boldface, cysteine residues are shown in red colour and amino acid position
of the cysteine residues in the human sequence is indicated above the alignment.
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